262492 Variability in Cancer Screening Behaviors: Comparing Florida to other U.S. regions

Tuesday, October 30, 2012 : 1:10 PM - 1:30 PM

Tainya C. Clarke, MPH, MS , Department of Epidemiology & Public Health, University of Miami, Miller School of Medicine, Miami, FL
Laura A. McClure, MSPH , Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
Hosanna Soler-Vila, PhD , Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, FL
William G. LeBlanc, PhD , Department of Epidemiology & Public Health, University of Miami, Miller School of Medicine - NIOSH Research Group, Miami, FL
John E. Lewis, PhD , Department of Psychiatry and Behavioral Sciences, University of Miami, Miami, FL
Manuel A. Ocasio, BA , Department of Epidemiology and Public Health, University of Miami, Miller School of Medicine, Miami, FL
Stacey L. Tannenbaum, PhD, RD, LD/N , Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
Jenelle Lin, BS , Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami
Kristopher L. Arheart, EdD , Department of Epidemiology & Public Health, University of Miami, Miller School of Medicine - NIOSH Research Group, Miami, FL
Lora E. Fleming, MD, PhD , Department of Epidemiology & Public Health, University of Miami, Miller School of Medicine - OHH Center and NIOSH Research Group, Miami, FL
David J. Lee, PhD , Epidemiology and Public Health, University of Miami, Miller School of Medicine, Miami, FL
Introduction: Previous studies have shown differences in cancer screening behavior by region, occupation, and race-ethnicity. We investigated differences in adherence to recommended cancer screening, comparing Florida to the rest of the United States. Methods: Following American Cancer Society guidelines, we measured rates of adherence to mammography, Papanicolaou (pap) and Prostate Specific Antigen (PSA) tests using National Health Interview Survey data (2003-2010). We compared Florida to the rest of the Southeast, the Northeast, Midwest, and the West separately. Results: After controlling for age and sociodemographic factors, at 69.6%, Floridians had higher rates of recommended PSA screening compared to the rest of South (prevalence = 63.8%; 95% CI = 62.2% 65.3%) , Northeast (64.4%; 61.8% 66.8%), Midwest (64.1%; 62.2% 65.9%), and West (61.6%; 59.6% 63.5%). However, the Northeast reported the highest recommended mammograms (77.9%; 76.8%-79.0%) and Pap-tests (76.6%; 75.6%-77.5%) respectively. Blue-collar workers were less likely to report adherence across all US regions. Hispanics in Florida were less likely to adhere to Pap-tests recommendations as compared to the rest of the US (all race/ethnicities). Across the regions the uninsured were up to 25% less likely to report having recommended screening than the insured. Discussion: Health insurance is strongly associated with adherence to recommended screening. Floridians are more compliant with recommended PSA screening compared to the rest of the US, but need to improve adherence to recommended mammograms and Pap-tests. Blue-collar workers may benefit from tailored health messages regarding adherence to cancer screening practices.

Learning Areas:
Chronic disease management and prevention
Epidemiology
Implementation of health education strategies, interventions and programs
Occupational health and safety
Planning of health education strategies, interventions, and programs
Public health or related public policy

Learning Objectives:
1. To examine adherence to recommended cancer screening within the United States. 2. To identify differences in adherence to recommended cancer screening, between Florida and the rest of the United States.

Keywords: Cancer Screening, National Health Interview Survey

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have spent the past couple years as a doctoral research trainee investigating disparities in cancer related health and risk behaviors among working survivors in the United States.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.